Global Infusion Therapy Market - Market Research Report

Global Infusion Therapy Market

Published Date:Jan 2026
Industry: Healthcare
Format: PDF
Page: 200
Forecast Period: 2026-2033
Historical Range: 2020-2024

Global Infusion Therapy Market Segmentation, By Product (Infusion Pumps {Volumetric Pumps, Syringe Pumps, Patient-Controlled Analgesia (PCA) Pumps, Ambulatory/Portable Pumps, Enteral Feeding Pumps}, Infusion Consumables & Accessories {IV Sets, IV Catheters & Cannulas, Needleless Connectors, Administration Sets}), By Indication (Cancer, Gastrointestinal Diseases/Disorders, Congestive Heart Failure, Rheumatoid Arthritis, Hemophilia, Immune Deficiencies, Others), By Therapy (Antibiotic/Antiviral, Anti-coagulation, Anti-emetics, Blood Component Stimulating Factor, Chemotherapy, Nutrition, Hydration, Pain Management), By Application (Chemotherapy, Diabetes, Gastrointestinal Diseases, Pain Management, Others), By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Homecare Settings)- Industry Trends and Forecast to 2033

 

Global Infusion Therapy Market size was valued at USD 29.7 billion in 2025 and is expected to reach at USD 54.6 billion in 2033, with a CAGR of 6.4% during the forecast period of 2025 to 2033.

 

Global Infusion Therapy Market Overview

The global infusion therapy market encompasses the delivery of fluids, medications, and nutrients directly into the bloodstream through intravenous or other parenteral routes. It plays a vital role in treating chronic and acute conditions such as cancer, diabetes, gastrointestinal disorders, and immune deficiencies. Market growth is driven by the rising burden of chronic diseases, an aging population, and increased use of biologics and specialty drugs. Technological advancements in infusion devices, along with the expanding adoption of home and ambulatory infusion services, are further enhancing treatment efficiency, patient comfort, and overall healthcare outcomes worldwide.

 

Global Infusion Therapy Market Scope

Global Infusion Therapy Market

Years Considered

Historical Period

2020 - 2024

Market Size (2025)

USD 29.7 Billion

Base Year

2025

Market Size (2033)

USD 54.6 Billion

Forecast Period

2026 - 2033

CAGR (2026 – 2033)

6.4%

Segments Covered

By Product

·         Infusion Pumps

o   Volumetric Pumps

o   Syringe Pumps

o   Patient-Controlled Analgesia (PCA) Pumps

o   Ambulatory/Portable Pumps

o   Enteral Feeding Pumps

·         Infusion Consumables & Accessories

o   IV Sets

o   IV Catheters & Cannulas

o   Needleless Connectors

o   Administration Sets

By Indicator

·         Cancer

·         Gastrointestinal Diseases/Disorders

·         Congestive Heart Failure

·         Rheumatoid Arthritis

·         Hemophilia

·         Immune Deficiencies

·         Others

By Therapy

·         Antibiotic/Antiviral

·         Anti-coagulation

·         Anti-emetics

·         Blood Component Stimulating Factor

·         Chemotherapy

·         Nutrition

·         Hydration

·         Pain Management

By Application

·         Chemotherapy

·         Diabetes

·         Gastrointestinal Diseases

·         Pain Management

·         Others

By End User

·         Hospitals

·         Ambulatory Surgical Centers

·         Clinics

·         Homecare Settings

Countries Catered

North America

·         United States

·         Canada

·         Mexico

Europe

·         United Kingdom

·         Germany

·         France

·         Spain

·         Italy

·         Rest of Europe

Asia Pacific

·         China

·         India

·         Japan

·         Australia

·         South Korea

·         Rest of Asia Pacific

Latin America

·         Brazil

·         Argentina

·         Rest of Latin America

Middle East & Africa

 

·         Saudi Arabia

·         South Africa

·         Rest of MEA

Key Companies

·         Option Care Health Inc.

·         Baxter International Inc.

·         ICU Medical, Inc.

·         B. Braun Melsungen AG

·         Terumo Corporation

·         Moog Inc.

·         Fresenius SE & Co. KGaA

·         Smiths Medical

·         JMS Co. Ltd.

·         CareFusion Corporation

 

Global Infusion Therapy Market Dynamics

The global infusion therapy market dynamics are shaped by a combination of clinical demand, technological innovation, and evolving healthcare delivery models. A major driver is the increasing prevalence of chronic and life-threatening diseases such as cancer, autoimmune disorders, diabetes, and cardiovascular conditions, which often require long-term and precise drug administration through infusion therapy. The growing geriatric population further accelerates demand, as older patients typically require continuous and supportive infusion-based treatments. In parallel, the rapid adoption of biologics, biosimilars, and specialty drugs—many of which cannot be administered orally—has significantly expanded the application scope of infusion therapy across therapeutic areas.

 

Technological advancements play a critical role in market expansion, with the development of smart infusion pumps, dose error reduction systems, and improved vascular access devices enhancing patient safety and treatment accuracy. Additionally, healthcare systems worldwide are increasingly shifting from hospital-based infusion toward home and ambulatory infusion settings to reduce costs and improve patient convenience. However, the market also faces restraints such as high treatment and device costs, risk of infusion-related complications, and stringent regulatory requirements governing infusion devices and drug administration. Limited access to skilled healthcare professionals, particularly in emerging economies, further challenges market growth.

 

Despite these constraints, opportunities continue to emerge through digital health integration, remote patient monitoring, and expanding healthcare infrastructure in developing regions. Overall, the interplay between rising clinical demand, innovation, cost pressures, and regulatory oversight defines the competitive and evolving landscape of the global infusion therapy market.

 

Global Infusion Therapy Market Segment Analysis

The global infusion therapy market segment analysis highlights a diverse and well-structured landscape driven by product innovation, expanding clinical applications, and evolving care settings. By product, infusion pumps represent a significant share of the market due to their critical role in accurate and controlled drug delivery. Volumetric pumps are widely used in hospitals for continuous fluid administration, while syringe pumps are preferred for low-volume and high-precision drug delivery, particularly in neonatal and critical care. Patient-controlled analgesia (PCA) pumps support effective pain management by allowing patients to self-administer controlled doses, whereas ambulatory or portable pumps are gaining traction with the growth of home infusion therapy. Enteral feeding pumps are increasingly utilized for long-term nutritional support. Infusion consumables and accessories, including IV sets, IV catheters and cannulas, needleless connectors, and administration sets, form a recurring revenue segment due to their high usage rates and single-use nature.

 

By indication, cancer remains a dominant segment owing to the extensive use of chemotherapy, immunotherapy, and supportive infusion treatments. Gastrointestinal diseases, congestive heart failure, rheumatoid arthritis, hemophilia, and immune deficiencies also contribute significantly, supported by the need for long-term and targeted infusion therapies. In terms of therapy type, chemotherapy and antibiotic or antiviral infusion therapies account for substantial demand, followed by nutrition, hydration, pain management, anti-coagulation, anti-emetics, and blood component stimulating factors, reflecting the broad therapeutic utility of infusion therapy.

 

By application, chemotherapy leads the market due to the rising global cancer burden, while diabetes, gastrointestinal diseases, and pain management applications continue to expand with improved infusion technologies. Other applications include critical care and supportive therapies. By end user, hospitals hold the largest market share due to advanced infrastructure and high patient inflow. However, ambulatory surgical centers, clinics, and homecare settings are witnessing rapid growth, driven by cost-efficiency, patient convenience, and the increasing shift toward decentralized healthcare delivery models.

 

Global Infusion Therapy Market Regional Analysis

The global infusion therapy market exhibits varied growth patterns across regions, influenced by healthcare infrastructure, disease prevalence, and adoption of advanced medical technologies. North America dominates the market due to its well-established healthcare system, high prevalence of chronic diseases, strong reimbursement frameworks, and early adoption of advanced infusion devices and home infusion services. Europe follows closely, supported by an aging population, increasing cancer incidence, and favorable government initiatives promoting patient safety and quality care. The Asia Pacific region is expected to witness the fastest growth, driven by rising healthcare expenditure, expanding hospital networks, growing awareness of infusion-based treatments, and a large patient pool in countries such as China and India. Latin America shows steady growth owing to improving healthcare infrastructure and increasing access to advanced therapies. Meanwhile, the Middle East and Africa market is gradually expanding, supported by healthcare investments, although growth remains constrained by limited access to skilled professionals and advanced infusion technologies.

 

Global Infusion Therapy Market Key Players

·         Option Care Health Inc.

·         Baxter International Inc.

·         ICU Medical, Inc.

·         B. Braun Melsungen AG

·         Terumo Corporation

·         Moog Inc.

·         Fresenius SE & Co. KGaA

·         Smiths Medical

·         JMS Co. Ltd.

·         CareFusion Corporation

 

Recent Developments

In May 2025, KabaFusion, a U.S. home and alternative site infusion therapy provider, acquired Infusion Care assets from Coram®, adding six infusion pharmacies and ambulatory suites and significantly expanding its reach across 26 states to serve more patients with chronic and acute therapies.

 

In January 2026, The National Home Infusion Association (NHIA) welcomed Inovalon to its Future of Infusion Advisory Council, a collaboration aimed at using data analytics and technology to address operational and clinical workflow challenges in home and alternate site infusion care.

 

Research Methodology

At Foreclaro Global Research, our research methodology is firmly rooted in a comprehensive and systematic approach to market research. We leverage a blend of reliable public and proprietary data sources, including industry reports, government publications, company filings, trade journals, investor presentations, and credible online databases. Our analysts critically evaluate and triangulate information to ensure accuracy, consistency, and depth of insights. We follow a top-down and bottom-up data modelling framework to estimate market sizes and forecasts, supplemented by competitive benchmarking and trend analysis. Each research output is tailored to client needs, backed by transparent data validation practices, and continuously refined to reflect dynamic market conditions.

Table of Contents

Chapter 1.  Introduction

1.1.  Report Description

1.2.  Key Market Segments

1.3.  Regulatory Scenario

1.4.  Executive Summary

Chapter 2.  Research Methodology

2.1.  Secondary Research

2.2.  Primary Research

2.3.  Secondary Analyst Tools and Models

Chapter 3.  Market Dynamics

3.1.  Market driver analysis

3.1.1.  Growing geriatric population requiring long-term and supportive care

3.1.2.  Increasing adoption of biologics and specialty drugs requiring infusion-based delivery

3.2.  Market restraint analysis

3.2.1.  High cost associated with infusion therapy equipment and specialty drugs

3.3.  Market Opportunity

3.3.1.  Integration of digital health and remote patient monitoring in infusion services

3.4.  Market Challenges

3.4.1.  Stringent regulatory requirements for infusion devices and drug administration

Chapter 4.  Market Variables and Outlook

4.1.  SWOT Analysis

4.1.1.  Strengths

4.1.2.  Weaknesses

4.1.3.  Opportunities

4.1.4.  Threats

4.2.  PESTEL Analysis

4.2.1.  Political Landscape

4.2.2.   Economic Landscape

4.2.3.  Social Landscape

4.2.4.  Technological Landscape

4.2.5.  Environmental Landscape

4.2.6.  Legal Landscape

4.3.  Porter’s Five Forces Analysis

4.3.1.  Bargaining Power of Suppliers

4.3.2.  Bargaining Power of Buyers

4.3.3.  Threat of Substitute

4.3.4.  Threat of New Entrant

4.3.5.  Competitive Rivalry

4.4.  Value Chain Analysis

4.5.  Covid Impact Analysis

Chapter 5.  Infusion Therapy Market: Product Estimates & Trend Analysis

5.1.  Infusion Therapy Market value share and forecast, (2020 to 2033)

5.2.  Incremental Growth Analysis and Infographic Presentation

5.3.  Infusion Pumps

5.3.1.  Volumetric Pumps

5.3.2.  Syringe Pumps

5.3.3.  Patient-Controlled Analgesia (PCA) Pumps

5.3.4.  Ambulatory/Portable Pumps

5.3.5.  Enteral Feeding Pumps

5.4.  Infusion Consumables & Accessories

5.4.1.  IV Sets

5.4.2.  IV Catheters & Cannulas

5.4.3.  Needleless Connectors

5.4.4.  Administration Sets

Chapter 6.  Infusion Therapy Market: Indicator Estimates & Trend Analysis

6.1.  Infusion Therapy Market value share and forecast, (2020 to 2033)

6.2.  Incremental Growth Analysis and Infographic Presentation

6.3.  Cancer

6.4.  Gastrointestinal Diseases/Disorders

6.5.  Congestive Heart Failure

6.6.  Rheumatoid Arthritis

6.7.  Hemophilia

6.8.  Immune Deficiencies

6.9.  Others

Chapter 7.  Infusion Therapy Market: Therapy Estimates & Trend Analysis

7.1.  Infusion Therapy Market value share and forecast, (2020 to 2033)

7.2.  Incremental Growth Analysis and Infographic Presentation

7.3.  Antibiotic/Antiviral

7.4.  Anti-coagulation

7.5.  Anti-emetics

7.6.  Blood Component Stimulating Factor

7.7.  Chemotherapy

7.8.  Nutrition

7.9.  Hydration

7.10. Pain Management

Chapter 8.  Infusion Therapy Market: Application Estimates & Trend Analysis

8.1.  Infusion Therapy Market value share and forecast, (2020 to 2033)

8.2.  Incremental Growth Analysis and Infographic Presentation

8.3.  Chemotherapy

8.4.  Diabetes

8.5.  Gastrointestinal Diseases

8.6.  Pain Management

8.7.  Others

Chapter 9.  Infusion Therapy Market: End User Estimates & Trend Analysis

9.1.  Infusion Therapy Market value share and forecast, (2020 to 2033)

9.2.  Incremental Growth Analysis and Infographic Presentation

9.3.  Hospitals

9.4.  Ambulatory Surgical Centers

9.5.  Clinics

9.6.  Homecare Settings

Chapter 10.      Infusion Therapy Market: Regional Estimates & Trend Analysis

10.1. Infusion Therapy Market value share and forecast, (2020 to 2033)

10.2. Incremental Growth Analysis and Infographic Presentation

10.3. North America

10.4. Europe

10.5. Asia Pacific

10.6. Middle East & Africa

10.7. Latin America

Chapter 11.      Infusion Therapy Market: Country Estimates & Trend Analysis

11.1. Infusion Therapy Market value share and forecast, (2020 to 2033)

11.2. Incremental Growth Analysis and Infographic Presentation

11.3. United States

11.4. Canada

11.5. Mexico

11.6. United Kingdom

11.7. France

11.8. Germany

11.9. Italy

11.10. Spain

11.11. China

11.12. India

11.13. Japan

11.14. South Korea

11.15. Australia

11.16. Brazil

11.17. Argentina

11.18. Saudi Arabia

11.19. South Africa

Chapter 12.      Competitive Landscape

12.1. Company Market Share Analysis

12.2. Vendor Landscape

12.3. Competition Dashboard

Chapter 13.      Company Profiles

13.1. Option Care Health Inc.

13.1.1. Company Overview

13.1.2. Financial Details

13.1.3. Product Analysis

13.1.4. Recent Developments

13.2. Baxter International Inc.

13.2.1. Company Overview

13.2.2. Financial Details

13.2.3. Product Analysis

13.2.4. Recent Developments

13.3. ICU Medical, Inc.

13.3.1. Company Overview

13.3.2. Financial Details

13.3.3. Product Analysis

13.3.4. Recent Developments

13.4. B. Braun Melsungen AG

13.4.1. Company Overview

13.4.2. Financial Details

13.4.3. Product Analysis

13.4.4. Recent Developments

13.5. Terumo Corporation

13.5.1. Company Overview

13.5.2. Financial Details

13.5.3. Product Analysis

13.5.4. Recent Developments

13.6. Moog Inc.

13.6.1. Company Overview

13.6.2. Financial Details

13.6.3. Product Analysis

13.6.4. Recent Developments

13.7. Fresenius SE & Co. KGaA

13.7.1. Company Overview

13.7.2. Financial Details

13.7.3. Product Analysis

13.7.4. Recent Developments

13.8. Smiths Medical

13.8.1. Company Overview

13.8.2. Financial Details

13.8.3. Product Analysis

13.8.4. Recent Developments

13.9. JMS Co. Ltd.

13.9.1. Company Overview

13.9.2. Financial Details

13.9.3. Product Analysis

13.9.4. Recent Developments

13.10. CareFusion Corporation

13.10.1.            Company Overview

13.10.2.            Financial Details

13.10.3.            Product Analysis

13.10.4.            Recent Developments

Segmentation

Infusion Therapy Market, Product Outlook (Revenue - USD Million, 2020 - 2033)

Infusion Pumps

·         Volumetric Pumps

·         Syringe Pumps

·         Patient-Controlled Analgesia (PCA) Pumps

·         Ambulatory/Portable Pumps

·         Enteral Feeding Pumps

Infusion Consumables & Accessories

·         IV Sets

·         IV Catheters & Cannulas

·         Needleless Connectors

·         Administration Sets

 

Infusion Therapy Market, Indication Outlook (Revenue - USD Million, 2020 - 2033)

Cancer

Gastrointestinal Diseases/Disorders

Congestive Heart Failure

Rheumatoid Arthritis

Hemophilia

Immune Deficiencies

Others

 

Infusion Therapy Market, Therapy Outlook (Revenue - USD Million, 2020 - 2033)

Antibiotic/Antiviral

Anti-coagulation

Anti-emetics

Blood Component Stimulating Factor

Chemotherapy

Nutrition

Hydration

Pain Management

 

Infusion Therapy Market, Application Outlook (Revenue - USD Million, 2020 - 2033)

Chemotherapy

Diabetes

Gastrointestinal Diseases

Pain Management

Others

 

Infusion Therapy Market, End user Outlook (Revenue - USD Million, 2020 - 2033)

Hospitals

Ambulatory Surgical Centers

Clinics

Homecare Settings

 

Infusion Therapy Market, Regional Outlook (Revenue - USD Million, 2020 - 2033)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Methodology

Review our research methodology and quality standards for details about source selection, validation, forecasting, and review.

At Foreclaro Global Research, our research methodology is built to deliver clear, data-backed intelligence that supports confident decision-making. By combining rigorous secondary research, primary validations, and advanced forecasting models, we produce insights that are not only reliable but also strategically relevant for our clients.

 

1. Defining the Research Framework

Every study begins with a clear understanding of our client’s goals. We establish the market scope, define critical variables, and build a research framework tailored to the specific project. This upfront clarity ensures that our findings are sharply aligned with the strategic questions being addressed.

 

2. Robust Data Collection

Our analysts extract high-integrity data from a broad mix of credible sources including government databases, annual reports, regulatory filings, trade publications, scientific journals, and trusted industry portals. This secondary research is then supported with targeted primary inputs through interviews with key industry stakeholders—such as executives, subject matter experts, and channel partners—to capture real-world insights and contextual depth.

 

3. Advanced Forecasting and Modeling

To estimate market size and growth, we employ a hybrid of top-down and bottom-up modeling techniques. Our analysts apply proven forecasting models using historical data trends, economic indicators, technology adoption rates, and demand patterns. Sensitivity analysis and scenario modeling (base, optimistic, conservative) are incorporated to account for market volatility and uncertainty.

 

4. Data Triangulation and Validation

Accuracy is non-negotiable. We cross-validate every data point by triangulating it across three dimensions: source credibility, numerical consistency, and contextual alignment. This ensures our insights are not just statistically correct but strategically dependable. Discrepancies are resolved using subject expertise and multi-perspective reviews to deliver a balanced, unbiased analysis.

 

5. Quality Assurance and Final Review

Before delivery, each report undergoes a stringent quality assurance process. Our research output is reviewed for structure, clarity, consistency, and compliance with global standards. The final deliverable is tailored for decision-makers, whether it's a comprehensive industry report, data dashboard, or strategic presentation.

 

Why Our Methodology Works

What sets us apart is our adaptive data architecture and our commitment to analytical clarity. Every study is built with flexibility to accommodate dynamic markets, while our team blends quantitative rigor with domain-specific expertise. This allows us to deliver research that goes beyond information, we deliver intelligence that leads to action.

Support Questions

What is the current and forecasted size of the global infusion therapy market??

The global infusion therapy market was valued at approximately USD 29.7 billion in 2025 and is projected to grow significantly over the forecast period, reaching over USD 54 billion by 2033, driven by rising demand for advanced therapeutic delivery solutions.

Which factors are driving growth in the infusion therapy market worldwide??
What are the major segments within the infusion therapy market??
Which regions are leading the infusion therapy market and why??
What are the primary challenges or limitations impacting infusion therapy adoption??

Choose License Type

Get a Sample Report

The sample report includes key data points such as market estimates, growth rates, market size, regional insights, and market segmentation

Request Sample Report